Journal: Discover. Oncology
Article Title: BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1
doi: 10.1007/s12672-024-00928-y
Figure Lengend Snippet: BRD4 alleviates ferroptosis induced by Erastin in a panel of five cell lines including HEK293T, HeLa, HepG2, RKO and PC3 cells. A Representative pictures and propidium iodide staining of HEK293T, HeLa, HepG2, RKO and PC3 cells after Erastin (20 μM) treatment for 24 h. Representative pictures and propidium iodide staining of ( B ) HEK293T cells, HeLa cells, ( C ) HepG2 cells, RKO cells and PC3 cells after being treated with DMSO, JQ-1 (1 μM), I-BET-762 (2 μM), Erastin (20 μM) or Erastin plus JQ-1, I-BET-762 respectively for 48 h. D CCK-8 was used to detect the cell viability of HEK293T cells and HeLa cells. E Representative pictures of HEK293T cells transfected with vector or plasmids encoding BRD4 after being treated with DMSO or Erastin (20 μM) respectively for 48 h. F Representative pictures of control and stable BRD4 knockdown cells in 293 T cells being treated with Erastin (20 μM) for 48 h. G Representative pictures of control and stable BRD4 knockdown cells in HeLa cells being treated with Erastin (20 μM) for 48 h. *p < 0 .05; **p < 0 .01; ***p < 0.001; ****p < 0.0001. Values are mean ± SD, n = 5
Article Snippet: The drugs include Erastin (B1524, APExBIO), JQ-1 (A1910, APExBIO), I-BET-762 (B1498, APExBIO), and MG132 (A2585, APExBIO).
Techniques: Staining, CCK-8 Assay, Transfection, Plasmid Preparation